Notify me when MPM BIOVENTURES 2018, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTSQ | AKTIS ONCOLOGY, INC. | Common Stock | 19% | $102,601 | 10,260,064 | ANSBERT GADICKE | 12 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|